All posts by PIER MARIA FORNASARI

PIER MARIA FORNASARI
2024-04-24

Dawn of CAR-T cell therapy in autoimmune diseases: Chinese Medical Journal review article highlights the potential and promise 

Credit: Chinese Medical JournalDaishi Tian from Huazhong University of Science and Technology Autoimmune disease (AID) refers to the condition in which the immune system identifies the body’s own cells and tissues as foreign, resulting in systemic inflammation. The immune system’s self-attack via autoreactive B and T immune cells and autoantibodies—antibodies against body’s own proteins—may present

Read More

No Comments InCAR-T
PIER MARIA FORNASARI
2024-04-24

FDA approves immunotherapy drug combo for non-muscle invasive bladder cancer after UCLA-led research shows improved outcomes for patients

Approval is based on findings from the QUILT 3.032 clinical trial, which was led by UCLA’s Dr. Karim Chamie The U.S. Food and Drug Administration (FDA) has approved the immunotherapy-boosting drug N-803, which is marketed under the brand name Anktiva, to be used in combination with the immunotherapy Bacillus Calmette-Guerin (BCG) for the treatment of

Read More

No Comments InCANCER IMMUNOTHERAPY
PIER MARIA FORNASARI
2024-04-17

AI makes retinal imaging 100 times faster, compared to manual method

NIH scientists use artificial intelligence called ‘P-GAN’ to improve next-generation imaging of cells in the back of the eye Researchers at the National Institutes of Health applied artificial intelligence (AI) to a technique that produces high-resolution images of cells in the eye. They report that with AI, imaging is 100 times faster and improves image

Read More

No Comments InARTIFICIAL INTELLIGENCE
PIER MARIA FORNASARI
2024-04-17

Physical Activity Reduces Stress-Related Brain Activity to Lower Cardiovascular Disease Risk

Key Takeaways New research indicates that physical activity lowers cardiovascular disease risk in part by reducing stress-related signaling in the brain. In the study, which was led by investigators at Massachusetts General Hospital (MGH), a founding member of the Mass General Brigham healthcare system, and published in the Journal of the American College of Cardiology, people

Read More

No Comments InRESEARCH
PIER MARIA FORNASARI
2024-04-17

New TRIPOD+AI guidelines reflect growing use of AI in healthcare research

The widespread use of artificial intelligence (AI) in medical decision-making tools has led to an update of the TRIPOD guidelines for reporting clinical prediction models. The new TRIPOD+AI guidelines are launched in the BMJ today. TheTRIPOD guidelines (which stands for Transparent Reporting of a Multivariable Prediction Model for Individual Prognosis Or Diagnosis) were developed in 2015

Read More

No Comments InARTIFICIAL INTELLIGENCE
PIER MARIA FORNASARI
2024-04-17

Adolescent Idiopathic Scoliosis patients showed pontine hypertrophy and asymmetry of diffusion parameters in the Brain Corticoreticular Pathway

Heavy school bags, poor posture, one-handed sports are often blamed for the development of curved spine in teens. Known as adolescent idiopathic scoliosis (AIS), it affects those aged 10 to 19 but has no known cause. A team from Singapore General Hospital (SGH) and National Neuroscience Institute (NNI) has now discovered that the answer to

Read More

No Comments InRESEARCH
PIER MARIA FORNASARI
2024-03-19

FDA Approves First Gene Therapy for Children with Metachromatic Leukodystrophy

The U.S. Food and Drug Administration approved Lenmeldy (atidarsagene autotemcel), the first FDA-approved gene therapy indicated for the treatment of children with pre-symptomatic late infantile, pre-symptomatic early juvenile or early symptomatic early juvenile metachromatic leukodystrophy (MLD).  Metachromatic leukodystrophy is a debilitating, rare genetic disease affecting the brain and nervous system. It is caused by a

Read More

No Comments InGENE THERAPY RARE DISEASES
PIER MARIA FORNASARI
2024-03-14

Mayo Clinic researchers find promise in new potential treatment for liver failure

A new drug has been shown to increase healing and regeneration of the liver after major surgery, according to a study published in the scientific journal Cell. Researchers hope that this could lead to more surgical options for patients diagnosed with advanced liver tumors and liver failure. “This research is significant because this is the first

Read More

No Comments InREGENERATIVE MEDICINE